Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury

Critical Care Medicine

Volumn 38, Issue 10, 2010, Pages 2037-2042

  Doi, Kent ^a,b   Noiri, Eisei ^a,b   Maeda Mamiya, Rui ^a   Ishii, Tomoko ^a   Negishi, Kousuke ^a   Hamasaki, Yoshifumi ^a   Fujita, Toshiro ^a   Yahagi, Naoki ^a   Koide, Hikaru ^c   Sugaya, Takeshi ^d   Nakamura, Tsukasa ^e  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KOTO HOSPITAL   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Shinmatsudo Central General Hospital   (Japan)

Author keywords

acute kidney injury; biomarker; cecal ligation and puncture; L type fatty acid binding protein; lipopolysaccharide; sepsis

Indexed keywords

ACETYLGLUCOSAMINIDASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN L TYPE; LIPOPOLYSACCHARIDE; MEROPENEM; UNCLASSIFIED DRUG;

ABDOMINAL INFECTION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; APACHE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY INJURY; LUNG INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOUSE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPSIS RELATED ORGAN FAILURE ASSESSMENT; SURVIVAL; TRANSGENIC MOUSE; UREA NITROGEN BLOOD LEVEL; URINARY TRACT INFECTION; ACUTE KIDNEY INJURY; ANIMAL; C57BL MOUSE; COMPLICATION; MIDDLE AGED; SHOCK, SEPTIC; URINE;

ACUTE KIDNEY INJURY; AGED; ANIMALS; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK, SEPTIC;

EID: 77957239451     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181eedac0     Document Type: Article

References (35)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
3. Hebert PC, Drummond AJ, Singer J, et al: A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993; 104: 230-235
4. Le Gall JR, Lemeshow S, Leleu G, et al: Customized probability models for early severe sepsis in adult intensive care patients. Intensive Care Unit Scoring Group. JAMA 1995; 273:644-650
5. Marshall JC, Cook DJ, Christou NV, et al: Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-1652
6. Russell JA, Singer J, Bernard GR, et al: Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med 2000; 28:3405-3411
7. Veerkamp JH, Peeters RA, Maatman RG: Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991; 1081: 1-24
8. Zimmerman AW, Veerkamp JH: New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci 2002; 59: 1096-1116
9. Haunerland NH, Spener F: Fatty acid-binding proteins-insights from genetic manipulations. Prog Lipid Res 2004; 43: 328-349
10. Noiri E, Doi K, Negishi K, et al: Urinary fatty acid-binding protein 1: An early predictive biomarker of kidney injury. Am J Physiol Renal Physiol 2009; 296:F669-F679
11. Yamamoto T, Noiri E, Ono Y, et al: Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 2007; 18:2894-2902
12. Portilla D, Dent C, Sugaya T, et al: Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008; 73:465-472
13. Nakamura T, Sugaya T, Node K, et al: Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropa-thy. Am J Kidney Dis 2006; 47:439-444
14. Nakamura T, Sugaya T, Koide H: Urinary liver-type fatty acid-binding protein in septic shock: Effect of polymyxin B-immobilized fiber hemoperfusion. Shock 2009; 31:454-459
15. Ferguson MA, Vaidya VS, Waikar SS, et al: Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010; 77:708-714
16. Sweetser DA, Lowe JB, Gordon JI: The nu-cleotide sequence of the rat liver fatty acid-binding protein gene. Evidence that exon 1 encodes an oligopeptide domain shared by a family of proteins which bind hydrophobic ligands. J Biol Chem 1986; 261:5553-5561
17. Kamijo A, Sugaya T, Hikawa A, et al: Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004; 165:1243-1255
18. Doi K, Hu X, Yuen PS, et al: AP214, an analogue of alpha-melanocyte- stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int 2008; 73:1266-1274
19. Doi K, Okamoto K, Negishi K, et al: Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol 2006; 168: 1413-1424
20. Tanaka T, Doi K, Maeda-Mamiya R, et al: Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Am J Pathol 2009; 174:1203-1211
21. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
22. Bellomo R, Ronco C, Kellum JA, et al: Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212
23. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
24. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
25. Aoki H, Kodama M, Tani T, et al: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994; 167:412-417
26. Miyaji T, Hu X, Yuen PS, et al: Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int 2003; 64:1620-1631
27. Marshall JC, Vincent JL, Fink MP, et al: Measures, markers, and mediators: Toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Round-table, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 2003; 31: 1560-1567
28. Coca SG, Yalavarthy R, Concato J, et al: Bi-omarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int 2008; 73:1008-1016
29. Bagshaw SM, Langenberg C, Haase M, et al: Urinary biomarkers in septic acute kidney injury. Intensive Care Med 2007; 33: 1285-1296
30. Trof RJ, Di Maggio F, Leemreis J, et al: Bi-omarkers of acute renal injury and renal failure. Shock 2006; 26:245-253
31. Zappitelli M, Washburn KK, Arikan AA, et al: Urine neutrophil gelatinase-associated li-pocalin is an early marker of acute kidney injury in critically ill children: A prospective cohort study. Crit Care 2007; 11:R84
32. Doi K, Yuen PS, Eisner C, et al: Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009; 20:1217-1221
33. Cerdá J, Cerdá M, Kilcullen P, et al: In severe acute kidney injury, a higher serum creati-nine is paradoxically associated with better patient survival. Nephrol Dial Transplant 2007; 22:2781-2784
34. Cartin-Ceba R, Afessa B, Gajic O: Low baseline serum creatinine concentration predicts mortality in critically ill patients independent of body mass index. Crit Care Med 2007; 35:2420-2423
35. Mackenzie I, Woodhouse J: C-reactive protein concentrations during bacteraemia: A comparison between patients with and without liver dysfunction. Intensive Care Med 2006; 32:1344-1351